Participating Faculty: Hemophilia: Managing the Cost of Care With a Focus on Patient Outcomes

Faculty

This supplement to The American Journal of Managed Care will provide an epidemiological and clinical overview of hemophilia, discuss current and emerging pharmacotherapeutic strategies, evaluate the burden of disease, and discuss the importance of involving healthcare professionals and managed care providers in the care of patients with hemophilia.

Kenneth A. Bauer, MD

Director

Thrombosis Clinical Research

Hematology-Oncology Division

Beth Israel Deaconess Medical Center

Professor

Department of Medicine

Harvard Medical School

Boston, Massachusetts

Dan R. Dalton, MS, RPh

Program Director

UNC Hemophilia Treatment Center Pharmacy

Division of Hematology/Oncology

University of North Carolina at Chapel Hill

Chapel Hill, North Carolina

Editorial Support

Kim Tran-Kerr, MD

Hitt Medical Writing, LLC

Alpharetta, Georgia

Faculty Disclosures

Kenneth A. Bauer, MD, has no relevant financial relationships with commercial interests to disclose.

Dan R. Dalton, MS, RPh, has no relevant financial relationships with commercial interests to disclose.

Editorial Support

Kim Tran-Kerr, MD, has no relevant financial relationships with commercial interests to disclose.

The American Journal of Managed Care

Publishing Staff—Jeff D. Prescott, PharmD, RPh, and Ida Delmendo have no relevant financial relationships with commercial interests to disclose.

Penn State College of Medicine

Planning staff and faculty involved in the development and review of this activity have no relevant financial relationships with commercial interests to disclose.

Pharmacy Times Office of Continuing Professional Education

Planning staff—David Heckard; Maryjo Dixon, RPh; Donna Fausak; and Nathalie Harden have no relevant financial relationships with commercial interests to disclose.

Disclosure Policy

According to the disclosure policy of the Penn State College of Medicine, all persons who are in a position to control content are required to disclose any relevant financial relationships with commercial interests. If a conflict is identified, it is the responsibility of the Penn State College of Medicine and Pharmacy Times Office of Continuing Profession Education to initiate a mechanism to resolve the conflict(s). The existence of these relationships is not viewed as implying bias or decreasing the value of the activity. All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.

Disclosure of Unapproved/Off-Label Use

The contents of this activity may include information regarding the use of products that may be inconsistent with or outside the approved labeling for these products in the United States. Participants should note that the use of these products outside current approved labeling is considered experimental and are advised to consult prescribing information for these products.

The information provided in this CE/CME activity is for continuing medical and pharmacy education purposes only and is not meant to substitute for the independent medical or pharmacy judgment of a physician or pharmacist relative to diagnostic, treatment, or management options for a specific patient’s medical condition.

The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of The American Journal of Managed Care, Pharmacy Times Office of Continuing Professional Education, and Penn State College of Medicine, or any of the companies that provided commercial support for this CE/CME activity.

Signed disclosures are on file at the office of The American Journal of Managed Care, Plainsboro, New Jersey.

Download PDF: Participating Faculty: Hemophilia: Managing the Cost of Care With a Focus on Patient Outcomes